David Worrall
David provides advice and support to the IVCC team on all matters with a legal, contract or intellectual property element. This includes advice on the various contracts which IVCC manages…
Screening chemistry
Although primarily focused on malaria, IVCC recognises that new tools and products are likely to be effective against a wide range of other vector-borne diseases.
Marking Progress and Challenges in the Fight Against Malaria: Reflections from the World Malaria Report
The newly released World Malaria Report, prepared by the World Health Organization (WHO), spotlights a pivotal moment in the fight against malaria. From 2000 to 2023, the global community averted…
IVCC receives new grant funding to support the development of innovative vector control tools for malaria
IVCC is pleased to confirm that it is the recipient of a new grant from the Bill & Melinda Gates Foundation. This new grant of $85 million over 5 years…
Vector Expedited Review Voucher (VERV) stakeholder event held in Washington DC
Duke University and US Government relations firm DC Legislative and Regulatory Services co-sponsored a Vector Expedited Review Voucher (VERV) stakeholder event in Washington DC on 28th February, 2024. The purpose of the meeting…
IVCC receives new grant funding from the Australian Government to support vector control innovation across the Indo-Pacific Region
IVCC is delighted to confirm that the Australian Government, has awarded IVCC a five-year, 17 million Australian dollar grant to advance the control of malaria in Papua New Guinea (PNG)…
Global Health Priority Box: MMV and IVCC make 240 compounds available to stimulate research into new drugs and insecticides
On World Mosquito Day 2022, MMV and the Innovative Vector Control Consortium (IVCC) launched the Global Health Priority Box to provide scientists with free access to a collection of compounds with confirmed activity against infectious and mosquito-borne diseases, and vectors of global concern.